| Organoid cultures as preclinical models of non–small cell lung cancer R Shi, N Radulovich, C Ng, N Liu, H Notsuda, M Cabanero, ... Clinical Cancer Research 26 (5), 1162-1174, 2020 | 194 | 2020 |
| The effects of fluid shear stress on proliferation and osteogenesis of human periodontal ligament cells L Zheng, L Chen, Y Chen, J Gui, Q Li, Y Huang, M Liu, X Jia, W Song, J Ji, ... Journal of biomechanics 49 (4), 572-579, 2016 | 41 | 2016 |
| BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer R Shi, SN Martins Filho, M Li, A Fares, J Weiss, NA Pham, O Ludkovski, ... Lung Cancer 146, 78-85, 2020 | 30 | 2020 |
| Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in PIK3CA-Mutant Lung Squamous Cell Carcinoma R Shi, M Li, V Raghavan, S Tam, M Cabanero, NA Pham, FA Shepherd, ... Clinical Cancer Research 24 (23), 5990-6000, 2018 | 27 | 2018 |
| Assessing therapy response in patient-derived xenografts J Ortmann, L Rampášek, E Tai, AS Mer, R Shi, EL Stewart, C Mascaux, ... Science Translational Medicine 13 (620), eabf4969, 2021 | 7 | 2021 |
| EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models SN Martins-Filho, J Weiss, NA Pham, Q Li, M Cabanero, A Fares, ... Lung Cancer 145, 144-151, 2020 | 5 | 2020 |
| An Anaplastic Lymphoma Kinase Immunohistochemistry–Negative but Fluorescence In Situ Hybridization–Positive Lung Adenocarcinoma Is Resistant to Crizotinib R Shi, M Varella-Garcia, M Li, O Ludkovski, A Danesh, C Ng, NA Pham, ... Journal of Thoracic Oncology 11 (12), 2248-2252, 2016 | 4 | 2016 |
| KuLGaP: A selective measure for assessing therapy response in patient-derived xenografts J Ortmann, L Rampášek, E Tai, AS Mer, R Shi, EL Stewart, C Mascaux, ... bioRxiv, 2020.09. 08.287573, 2020 | 2 | 2020 |
| MTE01. 02 Lung Patient Derived Xenograft and Organoid N Moghal, N Pham, R Shi, N Radulovich, M Li, V Raghavan, Q Li, D Wang, ... Journal of Thoracic Oncology 13 (10), S206-S207, 2018 | 1 | 2018 |
| Abstract B32: Fidelity of genomic and proteomic features of patient-derived xenografts of lung cancers NA Pham, D Wang, J Tong, CQ Zhu, L Li, W Zhang, R Shi, S Sakashita, ... Clinical Cancer Research 22 (16_Supplement), B32-B32, 2016 | 1 | 2016 |
| MA18. 07 Identification of Neuroendocrine Transformation in Anaplastic Lymphoma Kinase Rearranged (ALK+) Tumors After Tyrosine Kinase Inhibitors P Pal, A Fares, D Patel, E Stewart, N Perera-Low, A Grindley, F Allison, ... Journal of Thoracic Oncology 14 (10), S323-S324, 2019 | | 2019 |
| OA08. 01 Organoid Cultures as Novel Preclinical Models of Non-Small Cell Lung Cancer M Tsao, R Shi, N Radulovich, C Ng, H Notsuda, M Cabanero, ... Journal of Thoracic Oncology 14 (10), S225-S226, 2019 | | 2019 |
| P3. 03-008 Organoid Cultures of Lung Squamous Cell Carcinoma for Drug Screening R Shi, N Radulovich, M Cabanero, M Pintille, V Raghavan, R Quevedo, ... Journal of Thoracic Oncology 12 (11), S2276, 2017 | | 2017 |
| P2. 03b-071 Therapeutic Targeting of the Phosphatidylinositol-3 Kinase Pathway in Lung Squamous Cell Carcinoma: Topic: Biomarkers R Shi, M Li, M Cabanero, NA Pham, C Ng, F Shepherd, N Moghal, M Tsao Journal of Thoracic Oncology 12 (1), S978-S979, 2017 | | 2017 |
| P2. 03b-070 Establishment of Organoid Cell Lines from Lung Squamous Cell Carcinoma: Topic: Biomarkers R Shi, N Radulovich, C Ng, D Akshinthala, M Cabanero, M Li, NA Pham, ... Journal of Thoracic Oncology 12 (1), S978, 2017 | | 2017 |
